Core Viewpoint - The company is investing 1 billion yuan in a synthetic biology manufacturing project to enhance production capacity, improve efficiency, and maintain market competitiveness [1] Group 1: Investment and Project Details - The project will be constructed in three phases, funded entirely by the company's own resources [1] - The investment aims to address production capacity and efficiency bottlenecks, as existing production lines are insufficient to meet market demand [1] Group 2: Strategic Objectives - The project will strengthen the company's technological leadership by introducing advanced, energy-efficient, and highly automated production equipment [1] - The initiative is part of a core strategy to control costs, particularly in energy consumption, labor, and maintenance, by utilizing automated systems and optimizing site selection in Xinjiang [1]
回盛生物子公司拟10亿元投建新疆合成生物学智造项目